A leader in the production of pharmaceutical cannabidiol

and the development of innovative cannabidiol medicines

for heart disease

Pharmaceutical CBD

Developing CardiolRxTM for the rapidly growing medicinal cannabinoids market.

Acute Myocarditis

Cardiol is planning an international clinical study of acute myocarditis, a condition caused by inflammation in heart tissue.

Heart Failure

Committed to conquering a serious condition that affects more than 26 million people globally.

Email Updates

Sign up for our Cardiol Therapeutics newsletter to stay up to date with our most recent news, industry updates and press releases.

By submitting this form, you are consenting to receive marketing emails from: Cardiol Therapeutics Inc., 2265 Upper Middle Road East, Suite 602, Oakville, Ontario, L6H 0G5, CA, http://cardiolrx.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Mailchimp. Our Privacy Policy.

No, thanks